Why BD’s Wellstar partnership could reshape medication delivery inside hospitals
Hospitals need safer medication delivery, not more disconnected tech. BD and Wellstar are testing whether AI can close that workflow gap.
CE Mark clearance for BD Revello stent highlights growing competition in endovascular PAD therapies
BD secures EU CE Mark for the Revello vascular covered stent for iliac artery disease. Explore what this device could change for PAD treatment in Europe.
BD Research Cloud 7.0 introduces Horizon Panel Maker to automate complex experiment setup
BD launches an AI-powered panel design tool for flow cytometry. Find out how it’s reshaping immunology and cancer research automation.